|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.810 USD | -2.81% |
|
-12.41% | +99.48% |
| 06-29 | C4 Therapeutics, Inc.(NasdaqGS:CCCC) added to Russell 2000 Index | CI |
| 06-29 | C4 Therapeutics, Inc.(NasdaqGS:CCCC) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 421M 368M 340M 314M 592M 40.46B 603M 4.06B 1.59B 19.81B 1.58B 1.55B 68.22B | P/E 2026 * |
-4.08x | P/E 2027 * | -3.79x |
|---|---|---|---|---|---|
| Enterprise Value | 421M 368M 340M 314M 592M 40.46B 603M 4.06B 1.59B 19.81B 1.58B 1.55B 68.22B | EV / Sales 2026 * |
22.3x | EV / Sales 2027 * | 22x |
| Free-Float |
99.08% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: C4 Therapeutics, Inc.
| 1 day | -2.81% | ||
| 1 week | -12.41% | ||
| Current month | -18.42% | ||
| 1 month | -2.31% | ||
| 3 months | +38.04% | ||
| 6 months | +63.52% | ||
| Current year | +99.48% |
| 1 week | 3.78 |  | 4.4 |
| 1 month | 3.6 | | 5.17 |
| Current year | 1.69 | | 5.17 |
| 1 year | 1.69 | | 5.17 |
| 3 years | 1.06 | | 11.88 |
| 5 years | 1.06 | | 51.21 |
| 10 years | 1.06 | | 51.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 55 | 2020-10-01 |
Kendra Adams
DFI | Director of Finance/CFO | 49 | 2023-09-17 |
Paige Mahaney
CTO | Chief Tech/Sci/R&D Officer | 56 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Donna Grogan
BRD | Director/Board Member | 69 | 2022-07-28 |
Owen Hughes
BRD | Director/Board Member | 51 | 2023-11-19 |
Kenneth Anderson
BRD | Director/Board Member | 74 | 2015-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Free | Director | 3,341 | 0.0030% | ||
| 06-30 | Free | Founder | 2,650 | 0.0024% | ||
| 06-23 | Free | Director | 62,000 | 0.0561% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.81% | -12.41% | +60.08% | +13.73% | 433M | |
| -1.05% | +1.39% | +3.15% | +6.98% | 50.61B | |
| +0.55% | -2.88% | +382.07% | +593.81% | 39.11B | |
| +0.13% | -0.19% | +29.79% | -6.00% | 34.64B | |
| +0.86% | -0.78% | +21.58% | +56.15% | 33.79B | |
| -1.31% | -3.03% | +2.51% | +25.24% | 26.89B | |
| +0.13% | -0.52% | - | - | 16.47B | |
| +1.13% | -1.85% | +67.36% | +120.46% | 15.14B | |
| -0.72% | +0.12% | +14.69% | +16.95% | 13.85B | |
| +1.13% | -0.44% | +12.34% | -31.79% | 12.72B | |
| Average | -0.20% | -2.11% | +65.95% | +88.39% | 24.37B | |
| Weighted average by Cap. | -0.04% | -0.93% | +80.71% | +121.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.92M 16.54M 15.29M 14.13M 26.6M 1.82B 27.08M 182M 71.53M 890M 71.09M 69.52M 3.06B | 19.14M 16.73M 15.46M 14.29M 26.9M 1.84B 27.39M 184M 72.35M 900M 71.89M 70.31M 3.1B |
| Net income | -119M -104M -96.28M -88.95M -168M -11.45B -171M -1.15B -450M -5.61B -448M -438M -19.3B | -151M -132M -122M -112M -212M -14.48B -216M -1.45B -570M -7.09B -566M -554M -24.41B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | US$3.810 | -2.81% | 3,045,980 |
| 26-07-13 | US$3.920 | -3.45% | 3,013,353 |
| 26-07-10 | US$4.060 | -5.36% | 2,583,449 |
| 26-07-09 | US$4.290 | +2.39% | 2,536,283 |
| 26-07-08 | US$4.190 | -3.68% | 6,712,598 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CCCC Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
